Literature DB >> 25747822

Nitrofurantoin-induced pulmonary toxicity: A case report and review of the literature.

Wissam K Kabbara1, Melissa C Kordahi2.   

Abstract

This paper describes a case of lung injury attributed to the use of Nitrofurantoin and a review of the relevant literature. An 88-year-old woman was admitted to the floor for the evaluation of recent symptoms of dyspnea, fatigue and productive cough. She was initiated on nitrofurantoin 300 mg per day for the treatment of a urinary tract infection 3 days earlier. Upon examination, chest auscultation revealed bilateral inspiratory crackles. Chest radiograph showed bilateral airspace and interstitial infiltrates. Laboratory studies revealed an elevated white blood cell count of 13,500/μL (reference range = 5200-12,400/μL) and blood eosinophilia (10%, reference range: 0-7%). Using clinical judgment and the algorithm of Naranjo, it was determined that nitrofurantoin use was the probable cause of the patient's lung injury. Symptomatic improvement was observed shortly after the drug was discontinued. A review of information from several European and North American pharmacovigilance databases (through June 2014) identified several reports of suspected nitrofurantoin-induced toxicity, including reports of acute toxicity reactions, which were related in many ways to the case we are reporting here.
Copyright © 2015 King Saud Bin Abdulaziz University for Health Sciences. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Lung toxicity; Nitrofurantoin; Pulmonary toxicity

Mesh:

Substances:

Year:  2015        PMID: 25747822     DOI: 10.1016/j.jiph.2015.01.007

Source DB:  PubMed          Journal:  J Infect Public Health        ISSN: 1876-0341            Impact factor:   3.718


  11 in total

1.  Unrecognized Interstitial Lung Disease as a Result of Chronic Nitrofurantoin Use.

Authors:  Kerry Anne Rambaran; Charles F Seifert
Journal:  Drug Saf Case Rep       Date:  2016-12

Review 2.  Drug-induced eosinophilic pneumonia: A review of 196 case reports.

Authors:  Carmi Bartal; Iftach Sagy; Leonid Barski
Journal:  Medicine (Baltimore)       Date:  2018-01       Impact factor: 1.889

Review 3.  HRCT Patterns of Drug-Induced Interstitial Lung Diseases: A Review.

Authors:  Giulio Distefano; Luigi Fanzone; Monica Palermo; Francesco Tiralongo; Salvatore Cosentino; Corrado Inì; Federica Galioto; Ada Vancheri; Sebastiano E Torrisi; Letizia A Mauro; Pietro V Foti; Carlo Vancheri; Stefano Palmucci; Antonio Basile
Journal:  Diagnostics (Basel)       Date:  2020-04-22

4.  Nitrofurantoin Toxicity: A Near Case of Mistaken Identity.

Authors:  Jeffrey A Miskoff; Moiuz Chaudhri
Journal:  Cureus       Date:  2018-09-17

5.  Nitrofurantoin-associated Acute Pulmonary Toxicity Mimicking Severe Sepsis with Significantly Elevated Procalcitonin.

Authors:  Tahir Muhammad Abdullah Khan; Yusra Ansari; Abdul Hasan Siddiqui; Hall Matthew; Faraz Siddiqui
Journal:  Cureus       Date:  2019-08-29

6.  Risk factors of furazolidone-associated fever.

Authors:  Jiali Zhang; Chunling Rong; Chenyang Yan; Jie Chen; Wenjun Yang; Lingyan Yu; Haibin Dai
Journal:  PLoS One       Date:  2022-04-08       Impact factor: 3.240

7.  Consider Nitrofurantoin as a Cause of Lung Injury.

Authors:  Paulo Almeida; Eduarda Seixas; Beatriz Pinheiro; Pedro Ferreira; Ana Araújo
Journal:  Eur J Case Rep Intern Med       Date:  2019-10-30

8.  Reversible lung fibrosis in a 6-year-old girl after long term nitrofurantoin treatment.

Authors:  Lise Fischer Mikkelsen; Sune Rubak
Journal:  BMC Pulm Med       Date:  2020-11-26       Impact factor: 3.317

9.  Nitrofurantoin-Induced Pulmonary Toxicity: Always Review the Medication List.

Authors:  Caitlin Batzlaff; Matt Koroscil
Journal:  Cureus       Date:  2020-08-17

10.  Joint report of SBI (Brazilian Society of Infectious Diseases), FEBRASGO (Brazilian Federation of Gynecology and Obstetrics Associations), SBU (Brazilian Society of Urology) and SBPC/ML (Brazilian Society of Clinical Pathology/Laboratory Medicine): recommendations for the clinical management of lower urinary tract infections in pregnant and non-pregnant women.

Authors:  Patricia de Rossi; Sergio Cimerman; José Carlos Truzzi; Clóvis Arns da Cunha; Rosiane Mattar; Marinês Dalla Valle Martino; Maurício Hachul; Adagmar Andriolo; José Ananias Vasconcelos Neto; João Antônio Pereira-Correia; Antonia M O Machado; Ana Cristina Gales
Journal:  Braz J Infect Dis       Date:  2020-04-30       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.